Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds

NCT: NCT06543823 · RECRUITING

NCT IDNCT06543823
StatusRECRUITING
Start Date2025-04-30
SponsorAlaa Emara (OTHER)
First posted
Last updated

Brief Summary

To assess the use of Suprathel 250 for mucosal reconstruction in oropharyngeal defects. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑